Cargando…
Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma
BACKGROUND: Disruptor of telomeric silencing 1-like (Dot1l), a histone methyltransferase that targets the histone H3 lysine 79 (H3K79), has been reported that its high expression is associated with various cancers, while the association between Dot1l expression and clear-cell renal cell carcinoma (c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356697/ https://www.ncbi.nlm.nih.gov/pubmed/27713173 http://dx.doi.org/10.18632/oncotarget.12476 |